1. Home
  2. APGE vs PFSI Comparison

APGE vs PFSI Comparison

Compare APGE & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

N/A

Current Price

$134.75

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Logo PennyMac Financial Services Inc.

PFSI

PennyMac Financial Services Inc.

N/A

Current Price

$75.74

Market Cap

4.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
APGE
PFSI
Founded
2022
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.0B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
APGE
PFSI
Price
$134.75
$75.74
Analyst Decision
Strong Buy
Buy
Analyst Count
13
9
Target Price
$109.67
$128.11
AVG Volume (30 Days)
1.2M
665.8K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
1.35%
EPS Growth
N/A
59.25
EPS
N/A
1.94
Revenue
N/A
$984,629,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.96
P/E Ratio
N/A
$39.61
Revenue Growth
N/A
3.05
52 Week Low
$35.39
$71.68
52 Week High
$134.88
$160.36

Technical Indicators

Market Signals
Indicator
APGE
PFSI
Relative Strength Index (RSI) 77.42 42.07
Support Level $134.03 $71.68
Resistance Level $134.88 $87.46
Average True Range (ATR) 0.20 2.08
MACD -0.75 0.01
Stochastic Oscillator 87.65 34.36

Price Performance

Historical Comparison
APGE
PFSI

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.

Share on Social Networks: